Marco Viceconti will represent Mobilise-D in a Panel Discussion on “Digital Biomarkers & Digital Measurements – What Factors are Holding us Back and How Will We Overcome Them?”

Digital biomarkers / measurements aren’t new but there remain several core challenges that need to be addressed if these promising approaches are to have real impact. Showcasing leading, multi-stakeholder perspectives, this panel will tee-up the main themes of the meeting before diving into them deeper later on.

• How are companies dealing with a complex, fragmented European landscape?
• What regulatory conversations need to be had to advance the industry?
• How has the impact of COVID-19 accelerated the adoption of digital approaches in healthcare?
• Where are digital biomarkers / measurements having tangible impact on clinical trials?
• How are companies using digital and traditional biochemical biomarkers together to yield greater results?
• What do we hope to achieve by the end of this event?

Moderator: Lucia Cesnakova, Program Lead, DiMe Society

Yosef Safi Harb, Founder & CEO, Happitech

Katrine Christensen, Global Access & Strategy Lead, Biogen

Edouard Gasser, Co-Founder & CEO, Tilak Health

Marco Viceconti, Full Professor of Computational Biomechanics, University of Bologna

Full Digital Biomarkers and Digital Measurements Agenda here.